Insiders · NEUP

NEUP insider transactions

Neuphoria Therapeutics Inc. (NEUP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for NEUP

• 94d
  SEC Form 4 filed by Director Wilson David Ian

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 94d
  SEC Form 4 filed by Director Davies Peter Miles Winston

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 94d
  SEC Form 4 filed by Director Fisher Alan

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 94d
  SEC Form 4 filed by Director Ryan Jane

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 184d
  Large owner Lynx1 Capital Management Lp bought $3,283,108 worth of shares (639,110 units at $5.14) (SEC Form 4)

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 184d
  New insider Lynx1 Capital Management Lp claimed ownership of 236,218 shares (SEC Form 3)

  3 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 236d
  SEC Form 4 filed by President and CEO Papapetropoulos Spyros

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 341d
  Amendment: SEC Form 4 filed by President and CEO Papapetropoulos Spyros

  4/A - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 373d
  SEC Form 4 filed by President and CEO Papapetropoulos Spyros

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 373d
  SEC Form 4 filed by Director Davies Peter Miles Winston

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 373d
  SEC Form 4 filed by Director Ryan Jane

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 373d
  SEC Form 4 filed by Director Wilson David Ian

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)
• 373d
  SEC Form 4 filed by Director Fisher Alan

  4 - Neuphoria Therapeutics Inc. (0001191070) (Issuer)